Pharmacodynamic studies in cancer involve both preclinical and clinical phases. In preclinical studies, researchers use cell lines and animal models to evaluate the drug’s effects on cancer cells. Clinical studies involve multiple phases where the drug’s safety, efficacy, and optimal dosing are tested in human subjects. These studies are essential for understanding the drug’s behavior in the body and its impact on the tumor.
